New approach aims to wean transplant patients off harsh drugs
NCT ID NCT04804891
Summary
This early-stage study is testing whether giving intestinal transplant patients stem cells from their organ donor can help them safely reduce the strong anti-rejection medications they must take. These powerful drugs prevent organ rejection but carry high risks of serious infections and cancer. The goal is to see if the donor cells can help the patient's body better accept the new organ, allowing for lower medication doses while still controlling rejection.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTESTINAL TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Columbia University Irving Medical Center/NYP
RECRUITINGNew York, New York, 10032, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.